Patents

Roche Molecular Systems Products

Blood Screening

Blood Screening

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and foreign equivalent patents of each.

COBAS, COBAS OMNI, COBAS P, AMPERASE, AMPLIPREP, TAQMAN, and TAQSCREEN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and foreign equivalent patents of each.

COBAS, COBAS OMNI, COBAS P, AMPERASE, and TAQSCREEN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and foreign equivalent patents of each.

COBAS, COBAS OMNI, COBAS P, and AMPERASE are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and foreign equivalent patents of each.

COBAS, COBAS S, TAQMAN, TAQSCREEN, AMPLILINK, AMPERASE, and AMPLIPREP are trademarks of Roche. 
ROCHE RESPONSE CENTER is a service mark of Roche. 
The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners. 

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and foreign equivalent patents of each.

COBAS, COBAS S, TAQMAN, TAQSCREEN, AMPLILINK, AMPERASE, and AMPLIPREP are trademarks of Roche. 
ROCHE RESPONSE CENTER is a service mark of Roche. 
The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners. 

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and foreign equivalent patents of each.

COBAS, COBAS S, TAQMAN, TAQSCREEN, AMPLILINK, AMPERASE, and AMPLIPREP are trademarks of Roche. 
ROCHE RESPONSE CENTER is a service mark of Roche. 
The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners. 

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc. 
Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and foreign equivalent patents of each.

COBAS, COBAS OMNI, COBAS P, AMPERASE, and TAQSCREEN are trademarks of Roche. 
The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche. 

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche. 

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

MICROLAB® is a registered trademark of the Hamilton Company. 

BD PPT™ is a trademark of Becton Dickinson & Company.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche. 

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

MICROLAB® is a registered trademark of the Hamilton Company. 

BD PPT™ is a trademark of Becton Dickinson & Company.

VACUETTE® is a registered trademark of Greiner Bio-One GmbH LLC.

REALSTAR® is a registered trademark of Altona Diagnostics GmbH.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

Genomics and Oncology

Genomics and Oncology

COBAS, COBAS Z, and AMPERASE are trademarks of Roche.

TAZVERIK is a trademark of Epizyme, Inc., Cambridge, MA, USA.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, COBAS Z, AMPERASE, ZELBORAF, and COTELLIC are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, COBAS Z, AMPERASE, and TAQMELT are trademarks of Roche.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, COBAS Z, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain EGFR sequences in this product are covered by one or more patents of Genzyme Corp. and Dana Farber Cancer Institute and The General Hospital Corporation and licensed to Roche Molecular Systems, Inc. under U.S. Patent No. 7,964,349 and other U.S. and foreign patents pending.

© 2020 Roche Molecular Systems, Inc.

COBAS, COBAS Z, and AMPERASE are trademarks of Roche.

TAZVERIK is a trademark of Epizyme, Inc., Cambridge, MA, USA.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, HYBPROBE, MAGNAPURE, LIGHTCYCLER, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, HYBPROBE, MAGNAPURE, LIGHTCYCLER, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS is a trademark of Roche.

All other product names and trademarks are the property of their respective owners.

© 2020 Roche Molecular Systems, Inc.

Microbiology/STI/Women's Health

Microbiology/STI/Women's Health

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, 10059993, 10358675, 8609340, 9234250, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, 10059993, 10358675, 8609340, 9234250, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

EPPENDORF MULTIPETTE and EPPENDORF COMBITIP are trademarks of Eppendorf AG, Hamburg, Germany.

PRESERVCYT is a trademark of Hologic Corporation, Marlborough, MA.

REPLENS is a trademark of Lil’ Drug Store Products, Inc., Cedar Rapids, IA.

SUREPATH is a trademark of TriPath Imaging, Inc., Burlington, NC.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, 10059993, 10358675, 8609340, 9234250, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

PRESERVCYT is a trademark of Hologic Corporation, Marlborough, MA.

REPLENS is a trademark of Lil’ Drug Store Products, Inc., Cedar Rapids, IA.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, 10059993, 10358675, 8609340, 9234250, and 6727067, and foreign equivalent patents of each.

COBAS and AMPERASE are trademarks of Roche.

PRESERVCYT is a trademark of Hologic Corporation, Marlborough, MA.

REPLENS is a trademark of Lil’ Drug Store Products, Inc., Cedar Rapids, IA.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS and AMPERASE are trademarks of Roche.

PRESERVCYT is a trademark of Hologic Corporation, Marlborough, MA.

REPLENS is a trademark of Lil’ Drug Store Products, Inc., Cedar Rapids, IA.

EPPENDORF MULTIPETTE and EPPENDORF COMBITIP are trademarks of Eppendorf AG, Hamburg, Germany.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, 10059993, 10358675, 8609340, 9234250, and 6727067, and foreign equivalent patents of each.

COBAS, AMPERASE, and TAQMAN are trademarks of Roche.

MSWAB is a trademark of Copan Corporation, Murrietta, CA.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain technology in this product may be covered by one or more Patents owned by Becton, Dickinson and Company which are licensed to Roche Molecular Systems, Inc. and sold under license from Becton, Dickinson and Company.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, 10059993, 10358675, 8609340, 9234250, and 6727067, and foreign equivalent patents of each.

COBAS, TAQMAN, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, TAQMAN, and AMPERASE are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

 

cobas<sup>®</sup> Liat<sup>®</sup>

cobas® Liat®

US Patent Nos. 7718421, 8936933, 9708599, and 10443050.

 

COBAS and LIAT are trademarks of Roche.

 

ProClin® is a registered trademark of Rohm and Haas Company. 

 

All other product names and trademarks are the property of their respective owners.

 

© 2020 Roche Molecular Systems, Inc.

 

 

 

US Patent Nos. 7718421, 8936933, 9708599, and 10443050.

 

COBAS and LIAT are trademarks of Roche.

 

ProClin® is a registered trademark of Rohm and Haas Company. 

 

All other product names and trademarks are the property of their respective owners.

 

© 2020 Roche Molecular Systems, Inc.

 

 

 

US Patent Nos. 7718421, 8936933, 9708599, and 104430.

 

COBAS and LIAT are trademarks of Roche.

 

All other product names and trademarks are the property of their respective owners.

 

© 2020 Roche Molecular Systems, Inc.

 

US Patent Nos. 7718421, 8936933, 9708599, and 10443050.

 

COBAS and LIAT are trademarks of Roche.

 

ProClin® is a registered trademark of Rohm and Haas Company. 

 

All other product names and trademarks are the property of their respective owners.

 

© 2021 Roche Molecular Systems, Inc.

 

Virology

Virology

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, AMPERASE, AMPLIPREP, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, AMPERASE, AMPLIPREP, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

Vacutainer® is a registered trademark of Becton Dickinson & Company.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, 9963737, 9512494, 10041134, 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

Vacutainer® is a registered trademark of Becton Dickinson & Company.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, AMPERASE, AMPLICOR, AMPLICOR CMV MONITOR, AMPLIPREP, and TAQMAN are trademarks of Roche.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, 10793923, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8609340, 9234250, 8097717, 8192958, 10059993, 10358675, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

Vacutainer® is a registered trademark of Becton Dickinson & Company.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS P, AMPERASE, AMPLICOR, AMPLIPREP, AMPLILINK, and TAQMAN are trademarks of Roche.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS P, AMPERASE, AMPLICOR, AMPLIPREP, AMPLILINK, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

Vacutainer® is a registered trademark of Becton Dickinson & Company.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS P, AMPERASE, AMPLICOR, AAMPLIPREP, AMPLILINK, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

Vacutainer® is a registered trademark of Becton Dickinson & Company.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS P, AMPERASE, AMPLICOR, AMPLIPREP, AMPLILINK, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company.

THERMOMIXER® is a registered trademark of Eppendorf AG, Hamburg, Germany. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, COBAS P, AMPLICOR, AMPERASE, AMPLIPREP, AMPLILINK, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

ProClin® is a registered trademark of Rohm and Haas Company. 

THERMOMIXER® is a registered trademark of Eppendorf AG, Hamburg, Germany. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, AMPERASE, AMPLIPREP, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, AMPERASE, AMPLIPREP, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

ProClin® is a registered trademark of Rohm and Haas Company. 

THERMOMIXER® is a registered trademark of Eppendorf AG, Hamburg, Germany. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, AMPERASE, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, AMPERASE, AMPLIPREP, and TAQMAN are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, 8097717, 8192958, and 6727067, and foreign equivalent patents of each.

COBAS, AMPERASE, AMPLICOR, AMPLICOR CMV MONITOR, and TAQMAN are trademarks of Roche.

Vacutainer® is a registered trademark of Becton Dickinson & Company.

ProClin® is a registered trademark of Rohm and Haas Company. 

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, AMPERASE, AMPLIPREP, AAMPLICOR, AMPLILINK, and TAQMAN are trademarks of Roche.

ProClin® is a registered trademark of Rohm and Haas Company. 

TRITON® is a trademark of Union Carbide Corporation.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2020 Roche Molecular Systems, Inc.

COBAS, AMPERASE, AMPLIPREP, AMPLICOR, AMPLILINK, and TAQMAN are trademarks of Roche.

ProClin® is a registered trademark of Rohm and Haas Company. 

TRITON® is a trademark of Union Carbide Corporation.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

COBAS, AMPERASE, AMPLIPREP, AMPLICOR, AMPLILINK, and TAQMAN are trademarks of Roche.

ProClin® is a registered trademark of Rohm and Haas Company. 

Vacutainer® is a registered trademark of Becton Dickinson & Company.

TRITON® is a trademark of Union Carbide Corporation.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

Certain components of this product are covered by one or more US Patents and their foreign equivalents issued to Novartis Vaccines and Diagnostics, Inc. and licensed to Roche Molecular Systems, Inc. and F. Hoffman-La Roche Ltd.

© 2020 Roche Molecular Systems, Inc.

This product is covered by one or more of US Patent Nos. 8962293, 9102924, and 10059993, and foreign equivalent patents of each.

COBAS, COBAS OMNI, and AMPERASE are trademarks of Roche.

The trademark “Armored RNA®” is owned by Asuragen, Inc. and Cenetron Diagnostics, Ltd.

All other product names and trademarks are the property of their respective owners.

Carryover prevention technology in the AmpErase® enzyme is covered by U.S. Patent 7,687,247 owned by Life Technologies and licensed to Roche Molecular Systems, Inc.

© 2021 Roche Molecular Systems, Inc.

Instruments

Instruments

COBAS and LIAT are trademarks of Roche.

US Patent Nos. U.S. Patent Nos. 7,718,421; 8,936,933; and 9,005,551.

© 2015, Roche Molecular Systems, Inc.

The LightCycler® 480 System and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

The cobas® 4800 System and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

The cobas® 4800 System and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

The LightCycler® 96 System and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

The LightCycler® Nano Instrument and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

The LightCycler® 1536 System and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

The LightCycler® 2.0 Instrument and/or the use thereof is covered by US Patent Nos. 6036920; 6020141, 6268158, 6232085, 6214293, 6268218, 6303322, 6291192, 6849458, 7122321, and corresponding foreign patents owned by Life Technologies Corporation and licensed to Roche Molecular Systems, Inc. No other rights, explicitly or implicitly, to any other patents owned or controlled by Life Technologies Corporation or its affiliates, are granted hereby.

© 2014, Roche Diagnostics. All rights reserved.

Roche Sequencing Solutions

Pending U.S. Patent Application No. 13/981,541

Roche Diabetes Care Products

Lancing Systems

Lancing Systems

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® FastClix Lancing System:

The Accu-Chek® FastClix Lancing Device and the Accu-Chek® FastClix Lancets Drum, including their manufacture and/or use, either alone or in combination with other product(s), may be protected by one or more claims of one or more of the following patents:

7,785,338

ACCU-CHEK and ACCU-CHEK FASTCLIX are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® MultiClix Lancing System:

The Accu-Chek® MultiClix Lancing Device and the Accu-Chek® MultiClix Lancets Drum, including their manufacture and/or use, either alone or in combination with other product(s), may be protected by one or more claims of one or more of the following patents:

7,223,276; 7,273,484

ACCU-CHEK and ACCU-CHEK MULTICLIX are trademarks of Roche.

Insulin Delivery Systems

Insulin Delivery Systems

7,650,146

 

 

 

 7,273,472 

 

7,291,107

 

7,407,811

 

7,452,457

 

7,488,601

 

7,553,281

 

7,569,126 (exp. 10/08/2024)

 

7,595,726 (exp. 03/14/2025)

 

7,597,793 (exp. 10/17/2023)

 

7,635,351 (exp. 03/23/2026)

 

7,655,351 (exp. 02/01/2026)

 

7,862,544 (exp. 06/10/2022)

 

7,931,620 (exp. 07/12/2029)

 

8,117,481 (exp. 08/17/2030)

 

8,118,770 (exp. 06/09/2028)

 

8,147,460 (exp. 07/09/2029)

 

8,451,230 (exp. 06/04/2030)

 

8,533,475 (exp. 10/19/2029)

 

8,618,948 (exp. 02/04/2031)

 

8,652,387 (exp. 01/31/2026)

 

8,758,240 (exp. 05/01/2028)

 

U.S. Des. 617,802 (exp. 06/15/2024)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Aviva Plus Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more of the following patents:

7,547,524; 7,556,723; 7,727,467; 7,732,179; 7,749,437; 7,829,023; 7,892,849; 8,071,030; 8,142,721; 8,119,414; 8,211,379; 8,222,044

ACCU-CHEK and ACCU-CHEK AVIVA PLUS are trademarks of Roche.

Glucose Monitoring Systems

Glucose Monitoring Systems

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Aviva Meter:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,407,811; 7,452,457; 7,488,601; 7,569,126; 7,597,793; 8,377,707; 9,410,915

Accu-Chek® Aviva Plus Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,547,524; 7,556,723; 7,727,467; 7,732,179; 7,749,437; 7,829,023; 7,892,849; 8,071,030; 8,142,721; 8,119,414; 8,211,379; 8,222,044

Accu-Chek® Aviva Control Solution:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,071,384

Accu-Chek® Aviva Blood Glucose Monitoring System:

Combinations and/or processes including two or more of the Accu-Chek® Aviva Meter, the Accu-Chek® Aviva Plus Test Strip, and the Accu-Chek® Aviva Control Solution, as well as their manufacture and/or use alone or in combination with other product(s), may be protected by one or more claims of one or more of the following patents:

7,452,457; 7,488,601; 7,569,126; 7,597,793; 7,977,112; 8,071,384; 8,092,668; 8,361,291; 8,377,707; 8,663,442; 8,859,293; 9,410,915

ACCU-CHEK, ACCU-CHEK AVIVA, and ACCU-CHEK AVIVA PLUS are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Aviva Plus Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more of the following patents:

7,547,524; 7,556,723; 7,727,467; 7,732,179; 7,749,437; 7,829,023; 7,892,849; 8,071,030; 8,142,721; 8,119,414; 8,211,379; 8,222,044

ACCU-CHEK and ACCU-CHEK AVIVA PLUS are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Nano Meter:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,407,811; 7,452,457; 7,488,601; 7,569,126; 7,597,793; 8,377,707; 9,410,915

Accu-Chek® SmartView Test Strip::

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,547,524; 7,556,723; 7,727,467; 7,732,179; 7,749,437; 7,829,023; 7,892,849; 8,071,030; 8,142,721; 8,119,414; 8,211,379; 8,222,044 .

Accu-Chek® SmartView Control Solution:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,071,384

Accu-Chek® Nano Blood Glucose Monitoring System:

Combinations and/or processes including two or more of the Accu-Chek® Nano Meter, the Accu-Chek® SmartView Test Strip, and the Accu-Chek® SmartView Control Solution, as well as their manufacture and/or use alone or in combination with other product(s), may be protected by one or more claims of one or more of the following patents:

7,452,457; 7,488,601; 7,569,126; 7,597,793; 7,977,112; 8,071,384; 8,092,668; 8,361,291; 8,377,707; 8,663,442; 8,859,293; 9,410,915

ACCU-CHEK, ACCU-CHEK NANO, and ACCU-CHEK SMARTVIEW are trademarks of Roche.

Accu-Chek Compact Meter

7,501,097

D569,982

7,223,276

7,273,484

 

Accu-Chek Compact Test Strip Drums

7,547,524 (exp. 07/19/2025)

7,732,179 (exp. 10/13/2028)

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® SmartView Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,547,524; 7,556,723; 7,727,467; 7,732,179; 7,749,437; 7,829,023; 7,892,849; 8,071,030; 8,142,721; 8,119,414; 8,211,379; 8,222,044

ACCU-CHEK and ACCU-CHEK SMARTVIEW are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Guide Meter:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,545,148; 8,377,707; 8,715,571; 8,894,262; 9,063,146; 9,395,332; 9,410,915; 9,461,416; 9,614,202; 9,638,660; 9,976,977; 10,041,902; 10,197,524; 10,352,895; Des. 721,178; Des. 747,490

Accu-Chek® Guide Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,727,467; 7,892,849; 8,771,793; 8,888,973; 9,267,911; 9,754,708

Certain enzyme and related biosensor technologies and uses are covered by U.S. Patents owned by Toyobo Co. Ltd.

SmartPack® Test Strip Vial:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,844,725; 10,663,451; 11,237,151; Des. 698,459

Accu-Chek® Guide Control Solution:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,071,384

Accu-Chek® Guide Blood Glucose Monitoring System:

Combinations and/or processes including two or more of the Accu-Chek® Guide Meter, the Accu-Chek® Guide Test Strip, and the Accu-Chek® Guide Control Solution, as well as their manufacture and/or use alone or in combination with other product(s), may be protected by one or more claims of one or more of the following patents:

7,452,457; 7,488,601; 7,545,148; 7,569,126; 7,597,793; 7,977,112; 8,071,384; 8,092,668; 8,361,291; 8,377,707; 8,663,442; 8,715,571; 8,859,293; 8,888,973; 9,063,146; 9,267,911; 9,395,322; 9,395,332; 9,410,915; 9,461,416; 9,594,045; 9,594,052; 9,797,859; 10,119,931; 10,295,494; 10,809,221; 11,237,128

ACCU-CHEK, ACCU-CHEK GUIDE, and SMARTPACK are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Guide Me Meter:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,545,148; 8,377,707; 8,715,571; 9,063,146; 9,395,332; 9,410,915; 9,461,416; 9,638,660; 9,976,977; 10,041,902; 10,197,524; 10,352,895; Des. 721,178; Des. 747,490

Accu-Chek® Guide Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,727,467; 7,892,849; 8,771,793; 8,888,973; 9,267,911; 9,754,708

Certain enzyme and related biosensor technologies and uses are covered by U.S. Patents owned by Toyobo Co. Ltd.

SmartPack® Test Strip Vial:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,844,725; 10,663,451; 11,237,151; Des. 698,459

Accu-Chek® Guide Control Solution:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,071,384

Accu-Chek® Guide Me Blood Glucose Monitoring System:

Combinations and/or processes including two or more of the Accu-Chek® Guide Me Meter, the Accu-Chek® Guide Test Strip, and the Accu-Chek® Guide Control Solution, as well as their manufacture and/or use alone or in combination with other product(s), are protected by one or more claims of one or more of the following patents:

7,452,457; 7,488,601; 7,545,148; 7,569,126; 7,597,793; 7,977,112; 8,071,384; 8,092,668; 8,361,291; 8,377,707; 8,663,442; 8,715,571; 8,859,293; 8,888,973; 9,063,146; 9,267,911; 9,395,322; 9,395,332; 9,410,915; 9,461,416; 9,594,045; 9,594,052; 9,797,859; 10,119,931; 10,295,494; 10,809,221; 11,237,128

ACCU-CHEK, ACCU-CHEK GUIDE, ACCU-CHEK GUIDE ME, and SMARTPACK are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

Accu-Chek® Guide Link Meter:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,545,148; 8,377,707; 8,715,571; 8,894,262; 9,063,146; 9,395,332; 9,410,915; 9,461,416; 9,614,202; 9,638,660; 9,976,977; 10,041,902; 10,197,524; 10,352,895; Des. 721,178; Des. 747,490

Accu-Chek® Guide Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,727,467; 7,892,849; 8,771,793; 8,888,973; 9,267,911; 9,754,708

Certain enzyme and related biosensor technologies and uses are covered by U.S. Patents owned by Toyobo Co. Ltd.

SmartPack® Test Strip Vial:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,844,725; 10,663,451; 11,237,151; Des. 698,459

Accu-Chek® Guide Control Solution:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,071,384

Accu-Chek® Guide Link Blood Glucose Monitoring System:

Combinations and/or processes including two or more of the Accu-Chek® Guide Link Meter, the Accu-Chek® Guide Test Strip, and the Accu-Chek® Guide Control Solution, as well as their manufacture and/or use alone or in combination with other product(s), are protected by one or more claims of one or more of the following patents:

7,452,457; 7,488,601; 7,545,148; 7,569,126; 7,597,793; 7,977,112; 8,071,384; 8,092,668; 8,361,291; 8,377,707; 8,663,442; 8,715,571; 8,859,293; 8,888,973; 9,063,146; 9,267,911; 9,395,322; 9,395,332; 9,410,915; 9,461,416; 9,594,045; 9,594,052; 9,797,859; 10,119,931; 10,295,494; 10,809,221; 11,237,128

ACCU-CHEK, ACCU-CHEK GUIDE, ACCU-CHEK GUIDE LINK, and SMARTPACK are trademarks of Roche.

Article Embodying Patent(s)

U.S. Patent Nos.

ReliOn® Platinum Meter:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,545,148; 8,377,707; 8,715,571; 9,063,146; 9,395,332; 9,410,915; 9,461,416; 9,638,660; 9,976,977; 10,041,902; 10,197,524; 10,352,895; Des. 739,945; Des. 778,445

ReliOn® Platinum Test Strip:

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

7,727,467; 7,982,849; 8,771,793; 8,888,973; 9,267,911; 9,754,708

Certain enzyme and related biosensor technologies and uses are covered by U.S. Patents owned by Toyobo Co. Ltd.

Control Solution (when labeled as compatible with one or both of ReliOn® Platinum and Exacta Glance systems):

This product and/or its manufacture and/or its use either alone or in combination with other product(s) may be protected by one or more claims of one or more of the following patents:

8,071,384

ReliOn® Platinum Blood Glucose Monitoring System:

Combinations and/or processes including two or more of the ReliOn® Platinum Meter, the ReliOn® Platinum Test Strip, and the Control Solution labeled as compatible with one or both of ReliOn® Platinum and Exacta Glance, as well as their manufacture and/or use alone or with other product(s), may be protected by one or more claims of one or more of the following patents:

7,452,457; 7,488,601; 7,545,148; 7,569,126; 7,597,793; 7,977,112; 8,071,384; 8,092,668; 8,361,291; 8,377,707; 8,663,442; 8,715,571; 8,859,293; 8,888,973; 9,063,146; 9,267,911; 9,395,322; 9,395,332; 9,410,915; 9,461,416; 9,594,045; 9,594,052; 9,797,859; 10,119,931; 10,295,494; 10,809,221; 11,237,128

The trademarks “ReliOn” and “ReliOn Platinum” are owned by Walmart, Inc.
EXACTA and EXACTA GLANCE are trademarks of Roche.